Investor presentations
Fusion Antibodies PLC will host investor presentations in September and October 2025. A London investor event is scheduled for September 17, 2025, at 2:30 pm. The company will also present at the Proactive One2One Investor Forum on October 9, 2025, starting at 6:00 pm. Additionally, Fusion Antibodies intends to hold another investor event in Belfast city centre in September 2025, with details to be announced later. The company plans to publish its results for the year ended March 31, 2025, in the first half of September 2025, with further details forthcoming.
Select text to share a quote on X · sign in to keep highlights & notes in your FAB notes
Fusion Antibodies plc (AIM: FAB), specialists in pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications, announces that management will host two investor presentations in September and October 2025.
London investor event
The London investor event will take place on Wednesday, 17 September 2025 at 2.30pm. To register to attend this event, please use the link below or email fusion@walbrookpr.com.
I would like to attend the Fusion Antibodies London presentation.
Proactive Investors event
The Company will also present at the Proactive One2One Investor Forum on Thursday, 9 October 2025 at The Chesterfield Mayfair, 35 Charles Street, London, W1J 5EB. The event will start at 6.00pm. You can register to attend this event here.
The Company also intends to hold another investor event in Belfast city centre in September 2025, further details of which will be announced in due course. To register your interest to attend this event, please send an email using this link.
The Company will be publishing its results for the year ended 31 March 2025 in the first half of September 2025 and further details will be provided in due course.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.